1. Home
  2. CLDX vs ENVX Comparison

CLDX vs ENVX Comparison

Compare CLDX & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • ENVX
  • Stock Information
  • Founded
  • CLDX N/A
  • ENVX 2006
  • Country
  • CLDX United States
  • ENVX United States
  • Employees
  • CLDX N/A
  • ENVX N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ENVX Industrial Machinery/Components
  • Sector
  • CLDX Health Care
  • ENVX Miscellaneous
  • Exchange
  • CLDX Nasdaq
  • ENVX Nasdaq
  • Market Cap
  • CLDX 1.3B
  • ENVX 1.5B
  • IPO Year
  • CLDX 2008
  • ENVX N/A
  • Fundamental
  • Price
  • CLDX $22.77
  • ENVX $14.07
  • Analyst Decision
  • CLDX Buy
  • ENVX Strong Buy
  • Analyst Count
  • CLDX 9
  • ENVX 11
  • Target Price
  • CLDX $50.00
  • ENVX $18.45
  • AVG Volume (30 Days)
  • CLDX 1.2M
  • ENVX 7.8M
  • Earning Date
  • CLDX 08-07-2025
  • ENVX 07-30-2025
  • Dividend Yield
  • CLDX N/A
  • ENVX N/A
  • EPS Growth
  • CLDX N/A
  • ENVX N/A
  • EPS
  • CLDX N/A
  • ENVX N/A
  • Revenue
  • CLDX $7,559,000.00
  • ENVX $22,900,000.00
  • Revenue This Year
  • CLDX N/A
  • ENVX $55.18
  • Revenue Next Year
  • CLDX N/A
  • ENVX $253.52
  • P/E Ratio
  • CLDX N/A
  • ENVX N/A
  • Revenue Growth
  • CLDX 24.49
  • ENVX 77.59
  • 52 Week Low
  • CLDX $14.40
  • ENVX $5.27
  • 52 Week High
  • CLDX $47.00
  • ENVX $18.68
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 62.80
  • ENVX 80.87
  • Support Level
  • CLDX $20.76
  • ENVX $13.34
  • Resistance Level
  • CLDX $22.47
  • ENVX $14.50
  • Average True Range (ATR)
  • CLDX 1.22
  • ENVX 0.93
  • MACD
  • CLDX 0.17
  • ENVX 0.44
  • Stochastic Oscillator
  • CLDX 87.88
  • ENVX 93.61

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, Norway, the United States, Taiwan, and other regions.

Share on Social Networks: